c ballard
c ballard
Verified email at
Cited by
Cited by
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ...
Neurology 65 (12), 1863-1872, 2005
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
G Livingston, J Huntley, A Sommerlad, D Ames, C Ballard, S Banerjee, ...
The Lancet 396 (10248), 413-446, 2020
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
EA Holmes, RC O'Connor, VH Perry, I Tracey, S Wessely, L Arseneault, ...
The lancet psychiatry 7 (6), 547-560, 2020
Dementia prevention, intervention, and care
G Livingston, A Sommerlad, V Orgeta, SG Costafreda, J Huntley, D Ames, ...
The lancet 390 (10113), 2673-2734, 2017
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop
IG McKeith, D Galasko, K Kosaka, EK Perry, DW Dickson, LA Hansen, ...
Neurology 47 (5), 1113-1124, 1996
Alzheimer's disease
C Ballard, S Gauthier, A Corbett, C Brayne, D Aarsland, E Jones
the Lancet 377 (9770), 1019-1031, 2011
Vascular cognitive impairment
J T O'Brien, T Erkinjuntti, B Reisberg, G Roman, T Sawada, L Pantoni, ...
The Lancet Neurology 2 (2), 89-98, 2003
Defeating Alzheimer's disease and other dementias: a priority for European science and society
B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ...
The Lancet Neurology 15 (5), 455-532, 2016
Putting brain training to the test
AM Owen, A Hampshire, JA Grahn, R Stenton, S Dajani, AS Burns, ...
Nature 465 (7299), 775-778, 2010
Cognitive decline in Parkinson disease
D Aarsland, B Creese, M Politis, KR Chaudhuri, DH Ffytche, D Weintraub, ...
Nature Reviews Neurology 13 (4), 217-231, 2017
Donepezil and memantine for moderate-to-severe Alzheimer's disease
R Howard, R McShane, J Lindesay, C Ritchie, A Baldwin, R Barber, ...
New England Journal of Medicine 366 (10), 893-903, 2012
Atypical antipsychotics for aggression and psychosis in Alzheimer's disease
CG Ballard, J Waite, J Birks
Cochrane Database of Systematic Reviews, 2006
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
C Ballard, ML Hanney, M Theodoulou, S Douglas, R McShane, ...
The Lancet Neurology 8 (2), 151-157, 2009
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
J Cummings, S Isaacson, R Mills, H Williams, K Chi-Burris, A Corbett, ...
The Lancet 383 (9916), 533-540, 2014
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial
J Fossey, C Ballard, E Juszczak, I James, N Alder, R Jacoby, R Howard
Bmj 332 (7544), 756-761, 2006
Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa
CG Ballard, JT O'Brien, K Reichelt, EK Perry
Journal of clinical Psychiatry 63 (7), 553-558, 2002
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
BS Husebo, C Ballard, R Sandvik, OB Nilsen, D Aarsland
Bmj 343, 2011
Depression in Parkinson disease—epidemiology, mechanisms and management
D Aarsland, S Pĺhlhagen, CG Ballard, U Ehrt, P Svenningsson
Nature Reviews Neurology 8 (1), 35-47, 2012
Overlap between pathology of Alzheimer disease and vascular dementia
RN Kalaria, C Ballard
Alzheimer Disease & Associated Disorders 13, S115-S123, 1999
Parkinson disease-associated cognitive impairment
D Aarsland, L Batzu, GM Halliday, GJ Geurtsen, C Ballard, ...
Nature Reviews Disease Primers 7 (1), 1-21, 2021
The system can't perform the operation now. Try again later.
Articles 1–20